Karpus Investment Management’s Evergreen Corporation Class A Ordinary Share EVGR Stock Holding History

Karpus Investment Management’s Portfolio EVGR Stock Details EVGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,100	Closed	-$509K	–	225
2025 Q1	$509K	Hold	42,100	–	–	0.02%	185
2024 Q4	$500K	Sell	42,100 -1,250	-3%	-$14.7K	0.01%	194
2024 Q3	$506K	Hold	43,350	–	–	0.01%	202
2024 Q2	$498K	Hold	43,350	–	–	0.01%	207
2024 Q1	$492K	Hold	43,350	–	–	0.01%	218
2023 Q4	$483K	Sell	43,350 -70,000	-62%	-$775K	0.01%	223
2023 Q3	$1.24M	Sell	113,350 -4,000	-3%	-$43.5K	0.04%	199
2023 Q2	$1.27M	Sell	117,350 -1,500	-1%	-$16K	0.04%	219
2023 Q1	$1.24M	Hold	118,850	–	–	0.04%	245
2022 Q4	$1.22M	Sell	118,850 -5,400	-4%	-$55K	0.04%	272
2022 Q3	$1.25M	Sell	124,250 -152,500	-55%	-$1.53M	0.04%	300
2022 Q2	$2.76M	Buy	+276,750	New	+$2.76M	0.09%	221

Karpus Investment Management's EVGR Position: Q2 2025 in Review

Karpus Investment Management sold out of Evergreen Corporation Class A Ordinary Share (EVGR) in Q2 2025, closing a stake of 42,100 shares — an estimated $509K sold.

Karpus Investment Management first reported a position in EVGR in Q2 2022 and held it in 12 quarters. The position peaked at $2.76M in Q2 2022. 0 funds tracked by Wall St. Rank hold EVGR as of Q2 2025.

Karpus Investment Management reported no remaining Evergreen Corporation Class A Ordinary Share position as of Q2 2025 after selling out during the quarter.
Karpus Investment Management sold 42,100 Evergreen Corporation Class A Ordinary Share shares in Q2 2025, an estimated $509K.
Karpus Investment Management first reported a position in Evergreen Corporation Class A Ordinary Share in Q2 2022 and held it in 12 quarters.
Karpus Investment Management's Evergreen Corporation Class A Ordinary Share position peaked at $2.76M in Q2 2022.
0 funds tracked by Wall St. Rank held Evergreen Corporation Class A Ordinary Share as of Q2 2025.

Based on Karpus Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.